Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Comment by snootchybootchyon Aug 15, 2016 12:51pm
77 Views
Post# 25142645

RE:Add Merus to the list...

RE:Add Merus to the list...
kuatolives wrote: Of failed financial trickery. It's not a coincidence that all of Concordia, Valeant, Merus, Patient Home Monitoring are all going down in flames at around the exact same time with the exact same problem - increasing revenues increasing debt increasing losses.

And these are the companies that the so called experts on BNN flogged so hard. Now, all in flames.




Patient Home Monitoring went down in flames not because of debt but because of a myriad of other problems, with the primary one being a reduction of reimbursement rates from Medicare.  It was also way over promoted and the company really need to do a share consolidation.  But it looks like they have finally found a bottom and the stock looks like it wants to move up now.  Good cash flow generation with this company and still has strong revenue growth.  I would buy more but the sentiment on this company is so very negative.  The price may bounce around at these depressed levels for several quarters irrespective of company performance.  May be the most hated stock in Canada next to Concordia, Valeant, etc.

Speaking of going down in flames, check out what's happened to Aurinia Phamaceuticals today.  They reported deaths in their Phase 2b study.  I noticed the similarity in their name to Aralez.  I hope we do not get associated with those deaths by careless investors and money managers.




<< Previous
Bullboard Posts
Next >>